(Q35539971)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502106%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

review article

1 reference

title

Metformin inhibition of glycation processes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502106%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(03)72793-1

12 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1262-3636(03)72793-1

12 March 2024

author name string

P. Beisswenger

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502106

12 March 2024

D. Ruggiero-Lopez

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14502106

12 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14502106

12 March 2024

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502106%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

https://api.elsevier.com/content/article/PII:S1262363603727931?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S1262-3636(03)72793-1

https://api.elsevier.com/content/article/PII:S1262363603727931?httpAccept=text/plain

12 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S1262-3636(03)72793-1

12 March 2024

published in

Diabetes and Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502106%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502106%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

4 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502106%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

6S95-103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502106%20AND%20SRC:MED&resulttype=core&format=json

Negative consequences of glycation.

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Lilly Lecture 1993. Glycation and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Modification of the glyoxalase system in disease processes and prospects for therapeutic strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Mechanism for the formation of methylglyoxal from triosephosphates

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Enzyme catalysis: not different, just better

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification--a role in pathogenesis and antiproliferative chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Formation of glycine and aminoacetone from L-threonine by rat liver mitochondria.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Identification of fructose 3-phosphate in the lens of diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Metabolism of fructose-3-phosphate in the diabetic rat lens

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

A comparative study on proliferation, macromolecular synthesis and energy metabolism of in vitro-grown Ehrlich ascites tumor cells in the presence of glucosone, galactosone and methylglyoxal

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Glycoxidation and lipoxidation in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: evidence for intermediate stages of the Maillard reaction in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

The assay of methylglyoxal in biological systems byderivatization with 1,2-diamino-4,5-dimethoxybenzene

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Fluorimetric assay of D-lactate

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Glyoxalase System in Clinical Diabetes Mellitus and Correlation with Diabetic Complications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Relation between complications of type I diabetes mellitus and collagen-linked fluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Identification of alpha-dicarbonyl scavengers for cellular protection against carbonyl stress

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

The reaction of some dicarbonyl sugars with aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Glycation products and the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Novel inhibitors of advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Novel inhibitors of advanced glycation endproducts (part II).

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

1 reference

7 January 2021

Metformin reduces systemic methylglyoxal levels in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Left ventricular diastolic dysfunction in diabetic or hypertensive subjects: role of collagen alterations

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Kinetics and mechanism of the reaction of metformin with methylglyoxal

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Chelating activity of advanced glycation end-product inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Metformin: intrinsic vasculoprotective properties

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Negative Association between Erythrocyte Reduced Glutathione Concentration and Diabetic Complications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2803%2972793-1

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502106%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference